DOCUSATE SODIUM, SENNOSIDES

DOCUSATE SODIUM, SENNOSIDES was reported 4815 times

DOCUSATE SODIUM, SENNOSIDES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BILIRUBIN CONJUGATED ABNORMAL 2 0.0180
1 STOMA SITE ODOUR 3 0.0134
2 CONFUSIONAL AROUSAL 2 0.0124
3 ACUTE RIGHT VENTRICULAR FAILURE 2 0.0118
4 INCISION SITE DISCHARGE 2 0.0079
5 CULTURE WOUND POSITIVE 2 0.0077
6 AMMONIA ABNORMAL 3 0.0074
7 DIABETIC GANGRENE 2 0.0070
8 DEVICE MAINTENANCE ISSUE 4 0.0068
9 HEART FAILURE WITH PRESERVED EJECTION FRACTION 2 0.0068
10 STOMA SITE IRRITATION 3 0.0055
11 FEEDING TUBE USER 2 0.0055
12 STOMA SITE HYPERGRANULATION 3 0.0048
13 INFUSION SITE DISCHARGE 8 0.0046
14 MITRAL VALVE STENOSIS 3 0.0045
15 ALLERGY TO PLANTS 2 0.0044
16 EHLERS-DANLOS SYNDROME 2 0.0043
17 GENITAL ERYTHEMA 2 0.0040
18 MEDICAL DEVICE SITE DISCOMFORT 3 0.0037
19 INFUSION SITE OEDEMA 3 0.0036
20 ANAEMIA OF CHRONIC DISEASE 3 0.0033
21 CERUMEN IMPACTION 3 0.0033
22 ALCOHOL INTERACTION 6 0.0031
23 HAND DERMATITIS 2 0.0029
24 STOMA SITE ERYTHEMA 5 0.0027
25 STOMA SITE DISCHARGE 7 0.0026
26 HOSPICE CARE 25 0.0025
27 DEVICE DAMAGE 2 0.0025
28 NASAL ULCER 4 0.0025
29 FAILURE TO THRIVE 13 0.0025
30 HYPERPARATHYROIDISM SECONDARY 6 0.0024
31 DENTAL DISCOMFORT 2 0.0024
32 FRACTURED COCCYX 3 0.0024
33 PROTEIN TOTAL ABNORMAL 3 0.0023
34 FOOD REFUSAL 2 0.0023
35 RHONCHI 3 0.0022
36 CATHETER SITE SWELLING 2 0.0021
37 LIVING IN RESIDENTIAL INSTITUTION 4 0.0021
38 INFUSION SITE HAEMORRHAGE 7 0.0021
39 INFUSION SITE NODULE 2 0.0021
40 COCCYDYNIA 3 0.0020
41 CANCER PAIN 5 0.0020
42 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
43 INFUSION SITE MASS 2 0.0018
44 DERMATITIS CONTACT 21 0.0018
45 SHOULDER FRACTURE 3 0.0018
46 HYPERVOLAEMIA 9 0.0018
47 DEMENTIA WITH LEWY BODIES 2 0.0018
48 BLOOD LOSS ANAEMIA 4 0.0018
49 NEPHROGENIC ANAEMIA 8 0.0017
50 BLADDER OPERATION 2 0.0017
51 HYPORESPONSIVE TO STIMULI 2 0.0017
52 INCISION SITE PAIN 2 0.0017
53 GLOSSITIS 6 0.0017
54 CHRONIC RESPIRATORY FAILURE 2 0.0017
55 DEVICE ALARM ISSUE 3 0.0017
56 ESSENTIAL HYPERTENSION 3 0.0016
57 BLADDER PROLAPSE 2 0.0016
58 DIASTOLIC DYSFUNCTION 5 0.0016
59 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
60 CATHETER SITE HAEMORRHAGE 4 0.0016
61 PROTEIN TOTAL DECREASED 6 0.0016
62 BLOOD BILIRUBIN ABNORMAL 2 0.0016
63 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
64 NASAL SEPTUM DEVIATION 3 0.0015
65 MULTIPLE ALLERGIES 12 0.0015
66 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
67 GASTRITIS EROSIVE 7 0.0015
68 CARBOHYDRATE ANTIGEN 125 INCREASED 5 0.0015
69 CLUSTER HEADACHE 2 0.0015
70 INFUSION SITE RASH 2 0.0015
71 RENAL MASS 3 0.0015
72 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
73 NEUROGENIC BLADDER 3 0.0014
74 GENITAL RASH 2 0.0014
75 INFUSION SITE BRUISING 3 0.0014
76 THORACIC VERTEBRAL FRACTURE 4 0.0014
77 HAEMATOCRIT INCREASED 3 0.0013
78 INFUSION SITE ERYTHEMA 11 0.0013
79 EYE ALLERGY 2 0.0013
80 REHABILITATION THERAPY 5 0.0013
81 PRURITUS GENITAL 3 0.0013
82 VOLVULUS 3 0.0013
83 OXYGEN CONSUMPTION INCREASED 3 0.0013
84 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
85 PLASMA CELL MYELOMA RECURRENT 4 0.0012
86 POSTURE ABNORMAL 4 0.0012
87 DEVICE INFUSION ISSUE 3 0.0012
88 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
89 PLATELET DISORDER 3 0.0012
90 EXCORIATION 3 0.0012
91 APPENDICITIS PERFORATED 3 0.0012
92 ARTERIOSCLEROSIS 11 0.0012
93 AMYLOIDOSIS 2 0.0012
94 ACUTE SINUSITIS 2 0.0012
95 PLATELET COUNT ABNORMAL 7 0.0012
96 WEIGHT FLUCTUATION 12 0.0011
97 TASTE DISORDER 23 0.0011
98 GASTROINTESTINAL STROMAL TUMOUR 3 0.0011
99 INFUSION SITE SWELLING 7 0.0011
100 DECUBITUS ULCER 9 0.0011
101 BLOOD PHOSPHORUS INCREASED 3 0.0011
102 INFUSION SITE PAIN 14 0.0011
103 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
104 SKIN ABRASION 5 0.0011
105 BLOOD MAGNESIUM DECREASED 9 0.0010
106 ADRENAL DISORDER 2 0.0010
107 PARAPLEGIA 3 0.0010
108 FAECES HARD 4 0.0010
109 DEVICE POWER SOURCE ISSUE 3 0.0010
110 DROOLING 7 0.0010
111 SKIN LACERATION 11 0.0010
112 DIABETIC NEUROPATHY 5 0.0010
113 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
114 EYELID PAIN 2 0.0010
115 MENTAL STATUS CHANGES 27 0.0010
116 CACHEXIA 5 0.0010
117 ATRIAL TACHYCARDIA 2 0.0010
118 INFUSION SITE PRURITUS 3 0.0009
119 DEVICE CONNECTION ISSUE 2 0.0009
120 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
121 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
122 INTERVERTEBRAL DISC DISORDER 4 0.0009
123 CATHETER SITE ERYTHEMA 2 0.0009
124 COMPRESSION FRACTURE 5 0.0009
125 BLOOD TESTOSTERONE INCREASED 2 0.0009
126 RIB FRACTURE 19 0.0009
127 BACTERIAL SEPSIS 3 0.0009
128 COLONOSCOPY 2 0.0009
129 CLOSTRIDIUM TEST POSITIVE 2 0.0009
130 FOOD ALLERGY 7 0.0009
131 PELVIC FRACTURE 7 0.0009
132 PLASMA CELL MYELOMA 35 0.0009
133 WOUND DEHISCENCE 3 0.0009
134 GASTRIC POLYPS 2 0.0009
135 PERIORBITAL SWELLING 5 0.0009
136 ONYCHOCLASIS 6 0.0009
137 CERVICAL VERTEBRAL FRACTURE 3 0.0009
138 FLAT AFFECT 2 0.0009
139 ARTHRITIS INFECTIVE 4 0.0009
140 INFUSION SITE INFECTION 2 0.0009
141 BLOOD COUNT ABNORMAL 13 0.0009
142 TIBIA FRACTURE 4 0.0009
143 INCONTINENCE 9 0.0009
144 URINE ODOUR ABNORMAL 5 0.0008
145 TUMOUR MARKER INCREASED 4 0.0008
146 HAEMATOLOGICAL INFECTION 2 0.0008
147 DERMAL CYST 2 0.0008
148 DENTAL OPERATION 2 0.0008
149 STAPHYLOCOCCAL SEPSIS 4 0.0008
150 INFREQUENT BOWEL MOVEMENTS 2 0.0008
151 PRE-EXISTING CONDITION IMPROVED 5 0.0008
152 EYE INFECTION 9 0.0008
153 BLOOD SODIUM DECREASED 15 0.0008
154 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
155 CLAVICLE FRACTURE 3 0.0008
156 NEUTROPHIL COUNT INCREASED 8 0.0008
157 OESOPHAGEAL DISORDER 3 0.0008
158 MUSCULOSKELETAL CHEST PAIN 12 0.0008
159 CATHETER SITE PAIN 2 0.0008
160 KIDNEY INFECTION 15 0.0008
161 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
162 EXFOLIATIVE RASH 2 0.0008
163 CONSTIPATION 164 0.0008
164 BODY HEIGHT DECREASED 8 0.0007
165 BLOOD SODIUM INCREASED 2 0.0007
166 FEEDING DISORDER 15 0.0007
167 UNRESPONSIVE TO STIMULI 19 0.0007
168 PULMONARY THROMBOSIS 8 0.0007
169 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
170 SPINAL COMPRESSION FRACTURE 6 0.0007
171 THYROID FUNCTION TEST ABNORMAL 3 0.0007
172 HEART RATE ABNORMAL 4 0.0007
173 ANAL HAEMORRHAGE 2 0.0007
174 ANGIOPATHY 4 0.0007
175 DRUG TOLERANCE DECREASED 2 0.0007
176 SEASONAL ALLERGY 10 0.0007
177 HAND FRACTURE 5 0.0007
178 POOR PERIPHERAL CIRCULATION 3 0.0007
179 LUNG NEOPLASM 3 0.0007
180 NEOPLASM 8 0.0007
181 FULL BLOOD COUNT DECREASED 14 0.0007
182 FIBULA FRACTURE 2 0.0007
183 HORDEOLUM 3 0.0007
184 PYELONEPHRITIS 6 0.0007
185 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
186 ONYCHOMYCOSIS 3 0.0007
187 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
188 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
189 ORAL PAIN 15 0.0007
190 INFUSION SITE REACTION 2 0.0007
191 GASTROINTESTINAL INFECTION 6 0.0007
192 ATYPICAL PNEUMONIA 2 0.0007
193 BLOOD CULTURE POSITIVE 2 0.0007
194 BLOOD POTASSIUM DECREASED 20 0.0007
195 CEREBROVASCULAR DISORDER 2 0.0007
196 CENTRAL VENOUS CATHETERISATION 2 0.0007
197 VASCULAR DEVICE INFECTION 3 0.0007
198 EMERGENCY CARE 2 0.0007
199 HAEMOGLOBIN INCREASED 3 0.0007
200 SINUS DISORDER 13 0.0007
201 HAEMATOCRIT DECREASED 13 0.0007
202 DISEASE COMPLICATION 3 0.0007
203 LUMBAR VERTEBRAL FRACTURE 3 0.0007
204 PNEUMONIA BACTERIAL 6 0.0007
205 DIABETIC FOOT 2 0.0007
206 BRAIN NEOPLASM 6 0.0007
207 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
208 URINARY TRACT INFECTION 111 0.0007
209 RENAL FAILURE CHRONIC 5 0.0006
210 IRON DEFICIENCY ANAEMIA 6 0.0006
211 SMALL INTESTINAL OBSTRUCTION 8 0.0006
212 DECREASED ACTIVITY 7 0.0006
213 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
214 PRODUCT DISTRIBUTION ISSUE 6 0.0006
215 ROSACEA 3 0.0006
216 MULTIPLE MYELOMA 3 0.0006
217 STOMATITIS 39 0.0006
218 YELLOW SKIN 3 0.0006
219 DEVICE OCCLUSION 9 0.0006
220 BREAST CANCER RECURRENT 2 0.0006
221 DRUG EFFECT INCREASED 2 0.0006
222 BLOOD URINE PRESENT 12 0.0006
223 NERVE INJURY 7 0.0006
224 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
225 MALNUTRITION 7 0.0006
226 KIDNEY TRANSPLANT REJECTION 3 0.0006
227 ACUTE RESPIRATORY FAILURE 12 0.0006
228 PROCTALGIA 4 0.0006
229 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
230 ATELECTASIS 6 0.0006
231 HERNIA 12 0.0006
232 DIZZINESS POSTURAL 6 0.0006
233 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
234 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
235 MICTURITION URGENCY 7 0.0006
236 LABORATORY TEST ABNORMAL 18 0.0006
237 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
238 FLUID INTAKE REDUCED 3 0.0006
239 MENINGITIS 4 0.0006
240 ECONOMIC PROBLEM 9 0.0006
241 BRONCHIECTASIS 4 0.0006
242 DEHYDRATION 79 0.0006
243 POSTOPERATIVE WOUND INFECTION 4 0.0006
244 INSURANCE ISSUE 9 0.0006
245 AMMONIA INCREASED 3 0.0006
246 PSEUDOMONAS INFECTION 5 0.0006
247 POOR VENOUS ACCESS 6 0.0006
248 LOWER LIMB FRACTURE 11 0.0006
249 MASS 8 0.0006
250 EAR PRURITUS 2 0.0006
251 BLOOD CALCIUM INCREASED 5 0.0006
252 BLOOD LACTIC ACID INCREASED 3 0.0006
253 FULL BLOOD COUNT ABNORMAL 6 0.0006
254 CYSTITIS 18 0.0006
255 ILEUS 7 0.0006
256 PLATELET COUNT DECREASED 60 0.0006
257 RETCHING 12 0.0006
258 RED BLOOD CELL COUNT DECREASED 16 0.0006
259 SECRETION DISCHARGE 7 0.0006
260 NEUROPATHY PERIPHERAL 53 0.0006
261 ANAL INCONTINENCE 5 0.0006
262 FACIAL BONES FRACTURE 2 0.0006
263 BONE LESION 2 0.0006
264 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
265 GASTROENTERITIS VIRAL 10 0.0006
266 FAECES SOFT 4 0.0005
267 DEVICE KINK 2 0.0005
268 DYSSTASIA 16 0.0005
269 GASTROINTESTINAL PAIN 6 0.0005
270 INTESTINAL ISCHAEMIA 3 0.0005
271 HYPERKERATOSIS 3 0.0005
272 SKIN ULCER 14 0.0005
273 ARTHROPOD BITE 4 0.0005
274 CARDIAC DYSFUNCTION 2 0.0005
275 DYSPNOEA EXERTIONAL 20 0.0005
276 HIP FRACTURE 17 0.0005
277 DECREASED APPETITE 122 0.0005
278 PRODUCTIVE COUGH 25 0.0005
279 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
280 MUSCULOSKELETAL DISCOMFORT 9 0.0005
281 EXERCISE TOLERANCE DECREASED 3 0.0005
282 METASTASES TO LUNG 6 0.0005
283 CONCUSSION 4 0.0005
284 CELLULITIS 26 0.0005
285 SKIN WARM 3 0.0005
286 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
287 THROMBOSIS 41 0.0005
288 KNEE OPERATION 5 0.0005
289 HEAD INJURY 16 0.0005
290 FALL 168 0.0005
291 FURUNCLE 4 0.0005
292 NASAL DISCOMFORT 4 0.0005
293 HALLUCINATION 38 0.0005
294 MYOCLONUS 6 0.0005
295 GOUT 9 0.0005
296 WOUND 14 0.0005
297 AZOTAEMIA 2 0.0005
298 GANGRENE 3 0.0005
299 FUNGAL SKIN INFECTION 2 0.0005
300 END STAGE RENAL DISEASE 9 0.0005
301 BACK DISORDER 8 0.0005
302 MUSCLE SPASTICITY 6 0.0005
303 CONTUSION 47 0.0005
304 ABNORMAL FAECES 4 0.0005
305 HICCUPS 4 0.0005
306 SPINAL OPERATION 6 0.0005
307 HAEMOGLOBIN DECREASED 50 0.0005
308 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
309 SCOLIOSIS 3 0.0005
310 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
311 INTESTINAL OBSTRUCTION 18 0.0005
312 HALLUCINATIONS, MIXED 2 0.0005
313 CANDIDA INFECTION 8 0.0005
314 JOINT DISLOCATION 5 0.0005
315 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
316 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
317 HYPOPHAGIA 12 0.0005
318 ABSCESS LIMB 2 0.0005
319 ENTERITIS 3 0.0005
320 HAEMORRHAGE INTRACRANIAL 7 0.0005
321 VITAMIN D DECREASED 4 0.0005
322 HEREDITARY ANGIOEDEMA 5 0.0005
323 BREAST CANCER METASTATIC 5 0.0005
324 CARDIAC FLUTTER 3 0.0005
325 HIATUS HERNIA 6 0.0005
326 CARDIAC MURMUR 4 0.0005
327 EYE PAIN 26 0.0005
328 BONE CANCER 2 0.0005
329 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
330 BEDRIDDEN 6 0.0005
331 HYPOXIA 16 0.0005
332 LUNG INFILTRATION 4 0.0005
333 APPETITE DISORDER 3 0.0005
334 FLUID RETENTION 23 0.0005
335 BLOOD CREATINE INCREASED 2 0.0005
336 FACIAL PAIN 4 0.0004
337 IMPLANT SITE PAIN 2 0.0004
338 PRODUCT USE COMPLAINT 7 0.0004
339 OROPHARYNGEAL DISCOMFORT 4 0.0004
340 DYSPHAGIA 42 0.0004
341 PERIPHERAL SWELLING 68 0.0004
342 BODY TEMPERATURE INCREASED 9 0.0004
343 AGEUSIA 11 0.0004
344 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
345 ABNORMAL LOSS OF WEIGHT 3 0.0004
346 ABDOMINAL HERNIA 2 0.0004
347 SCAB 5 0.0004
348 ECCHYMOSIS 3 0.0004
349 LYMPHOEDEMA 3 0.0004
350 UROSEPSIS 4 0.0004
351 LARGE INTESTINE POLYP 3 0.0004
352 PROCEDURAL PAIN 12 0.0004
353 OROPHARYNGEAL PAIN 40 0.0004
354 ORAL DISCOMFORT 6 0.0004
355 RIGHT VENTRICULAR FAILURE 3 0.0004
356 COUGH 120 0.0004
357 METASTASES TO BONE 7 0.0004
358 HALLUCINATION, VISUAL 9 0.0004
359 DYSARTHRIA 16 0.0004
360 BLOOD PROLACTIN INCREASED 2 0.0004
361 COVID-19 PNEUMONIA 5 0.0004
362 THERMAL BURN 3 0.0004
363 FOOT FRACTURE 8 0.0004
364 SPUTUM DISCOLOURED 4 0.0004
365 BLOOD PRESSURE DECREASED 28 0.0004
366 BLOOD IRON DECREASED 5 0.0004
367 ATAXIA 5 0.0004
368 WEIGHT DECREASED 117 0.0004
369 HYPERSOMNIA 12 0.0004
370 POST PROCEDURAL COMPLICATION 8 0.0004
371 MYELODYSPLASTIC SYNDROME 6 0.0004
372 HUMERUS FRACTURE 2 0.0004
373 TONGUE DISORDER 3 0.0004
374 EAR PAIN 8 0.0004
375 MAJOR DEPRESSION 3 0.0004
376 VITAMIN D DEFICIENCY 4 0.0004
377 HAEMORRHOIDS 8 0.0004
378 PHARYNGEAL SWELLING 4 0.0004
379 CYTOPENIA 5 0.0004
380 ILLNESS 42 0.0004
381 SENSITIVE SKIN 3 0.0004
382 THERAPY INTERRUPTED 29 0.0004
383 HYPERCALCAEMIA 5 0.0004
384 LIGAMENT SPRAIN 4 0.0004
385 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
386 CYST 5 0.0004
387 ABDOMINAL TENDERNESS 2 0.0004
388 BLOOD PRESSURE ABNORMAL 8 0.0004
389 GLOSSODYNIA 9 0.0004
390 PRESCRIBED UNDERDOSE 8 0.0004
391 HEPATIC ENZYME ABNORMAL 2 0.0004
392 HYDRONEPHROSIS 3 0.0004
393 DEEP VEIN THROMBOSIS 26 0.0004
394 HYPERAMMONAEMIA 2 0.0004
395 CORONARY ARTERY STENOSIS 2 0.0004
396 PRODUCT ADMINISTRATION ERROR 8 0.0004
397 PLEURAL EFFUSION 24 0.0004
398 TROPONIN INCREASED 3 0.0004
399 DRY THROAT 4 0.0004
400 BOWEL MOVEMENT IRREGULARITY 3 0.0004
401 MALIGNANT NEOPLASM PROGRESSION 40 0.0004
402 SINUSITIS 40 0.0004
403 HYPOKALAEMIA 18 0.0004
404 ENDOCARDITIS 2 0.0004
405 CONFUSIONAL STATE 63 0.0004
406 INCREASED UPPER AIRWAY SECRETION 2 0.0004
407 MUSCULAR WEAKNESS 44 0.0004
408 LEUKOCYTOSIS 7 0.0004
409 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
410 PNEUMONIA 125 0.0004
411 THERAPY PARTIAL RESPONDER 6 0.0004
412 PULMONARY HYPERTENSION 8 0.0004
413 RESPIRATORY TRACT INFECTION 10 0.0004
414 TENDERNESS 4 0.0004
415 PETECHIAE 4 0.0004
416 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
417 TRANSFUSION 4 0.0004
418 ANHEDONIA 10 0.0004
419 ASTHENIA 143 0.0004
420 RENAL CYST 3 0.0004
421 FATIGUE 294 0.0004
422 RENAL PAIN 4 0.0004
423 GINGIVAL PAIN 3 0.0004
424 DYSPHONIA 22 0.0004
425 BLOOD PRESSURE FLUCTUATION 9 0.0004
426 DELIRIUM 13 0.0004
427 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
428 FOOD POISONING 2 0.0004
429 QUALITY OF LIFE DECREASED 5 0.0004
430 ACUTE KIDNEY INJURY 57 0.0004
431 PHOTOPHOBIA 7 0.0004
432 GINGIVITIS 2 0.0004
433 BACK PAIN 86 0.0004
434 BEHAVIOUR DISORDER 2 0.0004
435 CHEILITIS 2 0.0004
436 PHARYNGITIS STREPTOCOCCAL 4 0.0004
437 POST PROCEDURAL INFECTION 3 0.0004
438 OEDEMA 20 0.0004
439 MUSCULOSKELETAL DISORDER 7 0.0004
440 LETHARGY 21 0.0004
441 ABDOMINAL DISTENSION 38 0.0004
442 OEDEMA PERIPHERAL 44 0.0004
443 EPISTAXIS 27 0.0004
444 GASTRIC ULCER HAEMORRHAGE 2 0.0004
445 PNEUMONIA ASPIRATION 9 0.0004
446 FUNGAL INFECTION 12 0.0004
447 SKIN DISORDER 12 0.0004
448 POLLAKIURIA 15 0.0004
449 HYPOMAGNESAEMIA 5 0.0004
450 GAIT INABILITY 12 0.0004
451 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
452 FISTULA 4 0.0004
453 MITRAL VALVE INCOMPETENCE 4 0.0004
454 DISORIENTATION 14 0.0004
455 BLOOD PRESSURE INCREASED 54 0.0004
456 BLOOD CREATININE INCREASED 23 0.0004
457 GRANULOCYTOPENIA 2 0.0004
458 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
459 HAEMATOMA 9 0.0003
460 SKIN SWELLING 3 0.0003
461 DRY MOUTH 28 0.0003
462 HYPERVENTILATION 2 0.0003
463 DEVICE DISLOCATION 15 0.0003
464 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
465 MUCOSAL INFLAMMATION 9 0.0003
466 RASH MACULAR 12 0.0003
467 HYPOVOLAEMIA 2 0.0003
468 GROIN PAIN 3 0.0003
469 SPINAL OSTEOARTHRITIS 3 0.0003
470 METASTASES TO LIVER 6 0.0003
471 TUMOUR LYSIS SYNDROME 3 0.0003
472 SEPSIS 38 0.0003
473 ASCITES 10 0.0003
474 LYMPHOCYTE COUNT DECREASED 6 0.0003
475 BRADYKINESIA 2 0.0003
476 HOSPITALISATION 52 0.0003
477 EAR INFECTION 9 0.0003
478 OXYGEN SATURATION DECREASED 19 0.0003
479 CATARACT 20 0.0003
480 ABDOMINAL PAIN UPPER 69 0.0003
481 FLATULENCE 19 0.0003
482 PULMONARY OEDEMA 15 0.0003
483 THROAT IRRITATION 15 0.0003
484 RESPIRATORY DISORDER 10 0.0003
485 THERAPY NON-RESPONDER 15 0.0003
486 RASH PRURITIC 18 0.0003
487 INFLUENZA 37 0.0003
488 LIMB INJURY 9 0.0003
489 DYSPNOEA 187 0.0003
490 RESTLESS LEGS SYNDROME 6 0.0003
491 ADRENAL INSUFFICIENCY 4 0.0003
492 OSTEOPENIA 5 0.0003
493 PRESYNCOPE 8 0.0003
494 NO THERAPEUTIC RESPONSE 4 0.0003
495 LUNG DISORDER 16 0.0003
496 ENCEPHALOPATHY 8 0.0003
497 POOR QUALITY SLEEP 7 0.0003
498 ANAEMIA 62 0.0003
499 INFECTION 47 0.0003
500 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
501 BRONCHITIS 24 0.0003
502 CARDIAC FAILURE CONGESTIVE 26 0.0003
503 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
504 ANKLE FRACTURE 5 0.0003
505 HAEMOPTYSIS 9 0.0003
506 PHARYNGITIS 4 0.0003
507 DEMENTIA 9 0.0003
508 MENTAL DISORDER 14 0.0003
509 BACTERIAL INFECTION 6 0.0003
510 INFUSION SITE EXTRAVASATION 2 0.0003
511 HAEMATURIA 11 0.0003
512 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
513 MOBILITY DECREASED 23 0.0003
514 FLANK PAIN 3 0.0003
515 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
516 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
517 MUSCLE SPASMS 58 0.0003
518 CHRONIC KIDNEY DISEASE 24 0.0003
519 PNEUMOTHORAX 5 0.0003
520 RESPIRATORY TRACT CONGESTION 5 0.0003
521 SLEEP APNOEA SYNDROME 6 0.0003
522 INCREASED APPETITE 6 0.0003
523 SINUS BRADYCARDIA 3 0.0003
524 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
525 HEART RATE IRREGULAR 7 0.0003
526 HYPOTENSION 62 0.0003
527 NASAL CONGESTION 18 0.0003
528 SPEECH DISORDER 16 0.0003
529 PULMONARY EMBOLISM 29 0.0003
530 EYE DISORDER 10 0.0003
531 URINARY INCONTINENCE 9 0.0003
532 ORAL CANDIDIASIS 4 0.0003
533 SARS-COV-2 TEST POSITIVE 4 0.0003
534 PRODUCT DOSE OMISSION ISSUE 89 0.0003
535 CORONAVIRUS INFECTION 2 0.0003
536 UPPER LIMB FRACTURE 6 0.0003
537 CARDIAC FAILURE ACUTE 2 0.0003
538 OVARIAN CYST 3 0.0003
539 COAGULOPATHY 5 0.0003
540 CHOLECYSTITIS CHRONIC 2 0.0003
541 MEMORY IMPAIRMENT 41 0.0003
542 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
543 HYPOTHERMIA 3 0.0003
544 DISEASE PROGRESSION 35 0.0003
545 NAUSEA 233 0.0003
546 MOTOR DYSFUNCTION 3 0.0003
547 PALLOR 8 0.0003
548 EUPHORIC MOOD 3 0.0003
549 INITIAL INSOMNIA 3 0.0003
550 OSTEOPOROSIS 12 0.0003
551 PERIPHERAL COLDNESS 4 0.0003
552 LOCALISED INFECTION 7 0.0003
553 HYPERTRANSAMINASAEMIA 2 0.0003
554 ATRIAL FIBRILLATION 28 0.0003
555 ORTHOSTATIC HYPOTENSION 5 0.0003
556 FEBRILE NEUTROPENIA 19 0.0003
557 KNEE ARTHROPLASTY 6 0.0003
558 SCRATCH 3 0.0003
559 SKIN REACTION 4 0.0003
560 COLD SWEAT 5 0.0003
561 DUODENAL ULCER 2 0.0003
562 NEPHROLITHIASIS 13 0.0003
563 GAIT DISTURBANCE 54 0.0003
564 NASOPHARYNGITIS 52 0.0003
565 JOINT INJURY 6 0.0003
566 RENAL DISORDER 13 0.0003
567 BALANCE DISORDER 24 0.0003
568 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
569 ABDOMINAL PAIN LOWER 7 0.0003
570 BACK INJURY 3 0.0003
571 DIARRHOEA 178 0.0003
572 PRODUCT DOSE OMISSION 18 0.0003
573 VOMITING 129 0.0003
574 IMPAIRED HEALING 9 0.0003
575 WOUND INFECTION 3 0.0003
576 ASPIRATION 3 0.0003
577 BONE PAIN 16 0.0003
578 STAPHYLOCOCCAL INFECTION 9 0.0003
579 RASH ERYTHEMATOUS 13 0.0003
580 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
581 SKIN HAEMORRHAGE 4 0.0003
582 TOOTH DISORDER 6 0.0003
583 FEELING DRUNK 2 0.0003
584 DUODENAL ULCER PERFORATION 2 0.0003
585 GASTROINTESTINAL DISORDER 24 0.0003
586 COVID-19 47 0.0003
587 SNEEZING 6 0.0003
588 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
589 GENERAL SYMPTOM 2 0.0003
590 BLOOD CALCIUM DECREASED 3 0.0003
591 APHASIA 8 0.0003
592 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
593 COLITIS 10 0.0003
594 INTERNAL HAEMORRHAGE 3 0.0003
595 HIP ARTHROPLASTY 4 0.0003
596 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
597 DRY EYE 13 0.0003
598 MUSCLE TWITCHING 6 0.0003
599 SEIZURE 30 0.0003
600 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
601 OSTEOARTHRITIS 11 0.0003
602 NEOPLASM PROGRESSION 9 0.0003
603 ELECTROLYTE IMBALANCE 3 0.0003
604 POST PROCEDURAL HAEMORRHAGE 3 0.0003
605 DELUSION 4 0.0003
606 EJECTION FRACTION DECREASED 4 0.0003
607 ACUTE MYELOID LEUKAEMIA 4 0.0003
608 DEATH 221 0.0003
609 ABDOMINAL DISCOMFORT 43 0.0003
610 HYPERHIDROSIS 33 0.0003
611 BRAIN FOG 4 0.0003
612 PAIN IN EXTREMITY 75 0.0003
613 THERAPY CESSATION 13 0.0003
614 BACTERAEMIA 3 0.0003
615 DIVERTICULITIS 7 0.0003
616 CHOLECYSTITIS 3 0.0003
617 HALLUCINATION, AUDITORY 4 0.0003
618 ACCIDENT 3 0.0003
619 SCIATICA 4 0.0003
620 MUSCLE RIGIDITY 3 0.0003
621 WRIST FRACTURE 3 0.0003
622 WEIGHT INCREASED 56 0.0002
623 NEUTROPENIA 34 0.0002
624 SPINAL FRACTURE 5 0.0002
625 MUSCULOSKELETAL PAIN 13 0.0002
626 CHILLS 29 0.0002
627 TREMOR 41 0.0002
628 HYPERGLYCAEMIA 9 0.0002
629 RESPIRATORY FAILURE 18 0.0002
630 FIBROMYALGIA 6 0.0002
631 BLOOD POTASSIUM INCREASED 4 0.0002
632 CARDIAC DISORDER 23 0.0002
633 NEUTROPHIL COUNT DECREASED 10 0.0002
634 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
635 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
636 CARDIOMEGALY 3 0.0002
637 HYPERAESTHESIA 2 0.0002
638 ESCHERICHIA INFECTION 2 0.0002
639 ABNORMAL WEIGHT GAIN 3 0.0002
640 PAIN 149 0.0002
641 ANXIETY 69 0.0002
642 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
643 TOOTH EXTRACTION 3 0.0002
644 BLOOD UREA INCREASED 4 0.0002
645 ATRIAL SEPTAL DEFECT 2 0.0002
646 ACUTE MYOCARDIAL INFARCTION 7 0.0002
647 COGNITIVE DISORDER 11 0.0002
648 INADEQUATE ANALGESIA 2 0.0002
649 EATING DISORDER 5 0.0002
650 FEELING ABNORMAL 56 0.0002
651 ROTATOR CUFF SYNDROME 3 0.0002
652 IRRITABLE BOWEL SYNDROME 5 0.0002
653 ANOREXIA 3 0.0002
654 INSOMNIA 62 0.0002
655 RECTAL HAEMORRHAGE 10 0.0002
656 NECK PAIN 13 0.0002
657 PANCYTOPENIA 13 0.0002
658 ABDOMINAL PAIN 54 0.0002
659 FAECES DISCOLOURED 5 0.0002
660 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
661 DEVICE USE ISSUE 4 0.0002
662 GASTRITIS 6 0.0002
663 IMMUNE SYSTEM DISORDER 3 0.0002
664 TOOTH INFECTION 3 0.0002
665 MELAENA 5 0.0002
666 LYMPHADENOPATHY 8 0.0002
667 HEAD DISCOMFORT 4 0.0002
668 RASH 98 0.0002
669 CHEST DISCOMFORT 23 0.0002
670 HAIR TEXTURE ABNORMAL 3 0.0002
671 THIRST 4 0.0002
672 CEREBRAL HAEMORRHAGE 8 0.0002
673 HEADACHE 140 0.0002
674 HAEMOLYTIC ANAEMIA 2 0.0002
675 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
676 SINUS CONGESTION 3 0.0002
677 TACHYPNOEA 3 0.0002
678 PNEUMONITIS 6 0.0002
679 BONE DISORDER 4 0.0002
680 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
681 APPLICATION SITE RASH 3 0.0002
682 RESPIRATORY DISTRESS 6 0.0002
683 INCREASED TENDENCY TO BRUISE 2 0.0002
684 DYSURIA 8 0.0002
685 MALAISE 95 0.0002
686 DYSGEUSIA 16 0.0002
687 EYE SWELLING 8 0.0002
688 BLOOD CHOLESTEROL INCREASED 10 0.0002
689 CARPAL TUNNEL SYNDROME 3 0.0002
690 MIDDLE INSOMNIA 4 0.0002
691 APPENDICITIS 2 0.0002
692 BLISTER 12 0.0002
693 CHOLELITHIASIS 7 0.0002
694 LYMPHOPENIA 3 0.0002
695 FEELING HOT 13 0.0002
696 PAIN IN JAW 6 0.0002
697 CARDIAC FAILURE 17 0.0002
698 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
699 FRACTURE 4 0.0002
700 SINUS TACHYCARDIA 3 0.0002
701 DEPRESSION 48 0.0002
702 RENAL FAILURE 28 0.0002
703 VIRAL INFECTION 7 0.0002
704 BRONCHOSPASM 3 0.0002
705 URINARY RETENTION 7 0.0002
706 EYE INFLAMMATION 2 0.0002
707 SUBDURAL HAEMATOMA 3 0.0002
708 CARDIOGENIC SHOCK 3 0.0002
709 BLOOD GLUCOSE DECREASED 10 0.0002
710 AFFECT LABILITY 2 0.0002
711 HYPERTHYROIDISM 3 0.0002
712 JOINT SWELLING 25 0.0002
713 SEPTIC SHOCK 9 0.0002
714 HYPOKINESIA 3 0.0002
715 LIVER FUNCTION TEST ABNORMAL 6 0.0002
716 FLUID OVERLOAD 3 0.0002
717 PYREXIA 71 0.0002
718 ORAL HERPES 4 0.0002
719 HEPATOMEGALY 2 0.0002
720 DYSPEPSIA 20 0.0002
721 HYPERTENSION 43 0.0002
722 LOSS OF CONSCIOUSNESS 26 0.0002
723 WHEEZING 12 0.0002
724 ABASIA 5 0.0002
725 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
726 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
727 BLADDER DISORDER 2 0.0002
728 COLON CANCER 3 0.0002
729 HYPOAESTHESIA 30 0.0002
730 HYPOTONIA 2 0.0002
731 AGGRESSION 10 0.0002
732 BONE LOSS 3 0.0002
733 HOT FLUSH 15 0.0002
734 LACRIMATION INCREASED 6 0.0002
735 EMPHYSEMA 2 0.0002
736 ARTHROPATHY 11 0.0002
737 ARTHRALGIA 82 0.0002
738 DEVICE FAILURE 3 0.0002
739 DIABETES MELLITUS 15 0.0002
740 DRUG INTOLERANCE 19 0.0002
741 SKIN DISCOLOURATION 9 0.0002
742 THYROID DISORDER 3 0.0002
743 HELICOBACTER INFECTION 2 0.0002
744 CHEST PAIN 36 0.0002
745 LYMPHOMA 3 0.0002
746 LIMB DISCOMFORT 6 0.0002
747 RASH GENERALISED 5 0.0002
748 CRYING 7 0.0002
749 EYE DISCHARGE 2 0.0002
750 ROAD TRAFFIC ACCIDENT 8 0.0002
751 JOINT STIFFNESS 5 0.0002
752 MOUTH ULCERATION 4 0.0002
753 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
754 CEREBROVASCULAR ACCIDENT 32 0.0002
755 SOMNOLENCE 38 0.0002
756 DIZZINESS 94 0.0002
757 THROMBOCYTOPENIA 21 0.0002
758 SURGERY 11 0.0002
759 DRY SKIN 25 0.0002
760 FEAR 5 0.0002
761 SKIN CANCER 4 0.0002
762 PAIN OF SKIN 5 0.0002
763 RHINORRHOEA 12 0.0002
764 MUSCLE TIGHTNESS 3 0.0002
765 UNEVALUABLE EVENT 14 0.0002
766 THROAT TIGHTNESS 5 0.0002
767 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
768 SLEEP DISORDER 13 0.0002
769 BIPOLAR DISORDER 2 0.0002
770 PRODUCT PRESCRIBING ISSUE 4 0.0002
771 SKIN LESION 5 0.0002
772 VISION BLURRED 25 0.0002
773 CARDIAC ARREST 15 0.0002
774 VENTRICULAR TACHYCARDIA 3 0.0002
775 PHOTOSENSITIVITY REACTION 3 0.0002
776 DENTAL CARIES 2 0.0002
777 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
778 DISCOMFORT 11 0.0002
779 LEUKOPENIA 9 0.0002
780 STEVENS-JOHNSON SYNDROME 4 0.0002
781 SYNCOPE 18 0.0002
782 FEELING COLD 5 0.0002
783 DEVICE ISSUE 16 0.0002
784 FACE OEDEMA 3 0.0002
785 HEMIPARESIS 3 0.0002
786 MYALGIA 30 0.0002
787 IMPAIRED DRIVING ABILITY 2 0.0002
788 CHOLECYSTECTOMY 2 0.0002
789 ANGINA PECTORIS 5 0.0002
790 HERPES ZOSTER 10 0.0002
791 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
792 EXTRA DOSE ADMINISTERED 7 0.0002
793 DYSKINESIA 7 0.0002
794 HAEMORRHAGE 18 0.0002
795 PRODUCT USE ISSUE 32 0.0002
796 DEPRESSED MOOD 9 0.0002
797 BLOOD GLUCOSE INCREASED 32 0.0002
798 GALLBLADDER DISORDER 3 0.0002
799 CONDITION AGGRAVATED 51 0.0002
800 MIGRAINE 16 0.0002
801 HYPERLIPIDAEMIA 2 0.0002
802 FLUSHING 17 0.0002
803 ADVERSE DRUG REACTION 15 0.0002
804 SKIN EXFOLIATION 14 0.0002
805 OSTEOMYELITIS 3 0.0002
806 ARTHRITIS 13 0.0002
807 RENAL FAILURE ACUTE 7 0.0002
808 NEURALGIA 4 0.0002
809 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
810 DRUG INTERACTION 26 0.0002
811 HAEMATOCHEZIA 9 0.0002
812 GENERALISED OEDEMA 2 0.0002
813 PRURITUS 62 0.0002
814 HEPATIC STEATOSIS 3 0.0002
815 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
816 HEPATIC CIRRHOSIS 3 0.0002
817 PARAESTHESIA 25 0.0002
818 HYPOCALCAEMIA 3 0.0002
819 GASTRIC ULCER 3 0.0002
820 HAEMATEMESIS 4 0.0002
821 FEELING JITTERY 3 0.0002
822 EMOTIONAL DISTRESS 19 0.0002
823 GLAUCOMA 3 0.0002
824 MOVEMENT DISORDER 5 0.0002
825 NIGHT SWEATS 5 0.0002
826 ANAPHYLACTIC SHOCK 4 0.0002
827 ERUCTATION 3 0.0002
828 PRESCRIBED OVERDOSE 3 0.0002
829 DYSTONIA 3 0.0002
830 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
831 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
832 PALPITATIONS 18 0.0002
833 SKIN FISSURES 3 0.0002
834 PRODUCT USE IN UNAPPROVED INDICATION 38 0.0002
835 SUICIDAL IDEATION 14 0.0002
836 SEDATION 4 0.0002
837 OSTEONECROSIS 5 0.0002
838 ABNORMAL BEHAVIOUR 6 0.0002
839 HEART RATE INCREASED 15 0.0002
840 ADVERSE REACTION 2 0.0002
841 VISUAL ACUITY REDUCED 5 0.0002
842 EYE HAEMORRHAGE 2 0.0001
843 NEOPLASM MALIGNANT 10 0.0001
844 IRRITABILITY 9 0.0001
845 SWELLING 14 0.0001
846 CYTOKINE RELEASE SYNDROME 3 0.0001
847 EYE PRURITUS 5 0.0001
848 PRODUCT PHYSICAL ISSUE 3 0.0001
849 TYPE 2 DIABETES MELLITUS 5 0.0001
850 TOXICITY TO VARIOUS AGENTS 25 0.0001
851 BLOOD BILIRUBIN INCREASED 4 0.0001
852 BONE MARROW FAILURE 3 0.0001
853 COMA 7 0.0001
854 DRUG TOXICITY 2 0.0001
855 HEPATIC ENZYME INCREASED 10 0.0001
856 CORONARY ARTERY OCCLUSION 2 0.0001
857 RESPIRATORY ARREST 4 0.0001
858 ABNORMAL DREAMS 4 0.0001
859 HYPOGLYCAEMIA 7 0.0001
860 CARDIO-RESPIRATORY ARREST 6 0.0001
861 COORDINATION ABNORMAL 2 0.0001
862 WITHDRAWAL SYNDROME 6 0.0001
863 ALOPECIA 28 0.0001
864 HYPERKALAEMIA 5 0.0001
865 HEART RATE DECREASED 5 0.0001
866 LIVER FUNCTION TEST INCREASED 3 0.0001
867 HYPOACUSIS 6 0.0001
868 ACCIDENTAL UNDERDOSE 2 0.0001
869 DEVICE LEAKAGE 6 0.0001
870 ANOSMIA 2 0.0001
871 APATHY 2 0.0001
872 GASTROENTERITIS 2 0.0001
873 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
874 MUSCULOSKELETAL STIFFNESS 12 0.0001
875 PSYCHOTIC DISORDER 4 0.0001
876 CARDIOMYOPATHY 2 0.0001
877 LIVER DISORDER 6 0.0001
878 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
879 RENAL INJURY 4 0.0001
880 IMMUNODEFICIENCY 2 0.0001
881 INFLUENZA LIKE ILLNESS 11 0.0001
882 HYPOAESTHESIA ORAL 2 0.0001
883 CORONARY ARTERY DISEASE 4 0.0001
884 RENAL IMPAIRMENT 11 0.0001
885 DRUG DISPENSING ERROR 2 0.0001
886 TINNITUS 6 0.0001
887 DEVICE ADHESION ISSUE 2 0.0001
888 DISTURBANCE IN ATTENTION 7 0.0001
889 PERICARDIAL EFFUSION 3 0.0001
890 HYPERSENSITIVITY 24 0.0001
891 OFF LABEL USE 113 0.0001
892 BURNING SENSATION 9 0.0001
893 BONE DENSITY DECREASED 4 0.0001
894 ANAPHYLACTIC REACTION 7 0.0001
895 OCULAR HYPERAEMIA 6 0.0001
896 MOOD SWINGS 4 0.0001
897 HYPOTHYROIDISM 4 0.0001
898 METABOLIC ACIDOSIS 4 0.0001
899 HYPONATRAEMIA 7 0.0001
900 TACHYCARDIA 11 0.0001
901 MENTAL IMPAIRMENT 3 0.0001
902 UNDERDOSE 9 0.0001
903 SWELLING FACE 8 0.0001
904 BLINDNESS 5 0.0001
905 AGITATION 9 0.0001
906 EYE IRRITATION 7 0.0001
907 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
908 CYTOMEGALOVIRUS INFECTION 2 0.0001
909 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
910 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
911 INFLAMMATION 6 0.0001
912 EXPOSURE VIA SKIN CONTACT 3 0.0001
913 ASTHMA 13 0.0001
914 DRUG DOSE OMISSION 19 0.0001
915 ECZEMA 6 0.0001
916 PANCREATITIS 6 0.0001
917 BRADYCARDIA 6 0.0001
918 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
919 JAUNDICE 3 0.0001
920 FREQUENT BOWEL MOVEMENTS 3 0.0001
921 PANIC ATTACK 4 0.0001
922 TREATMENT NONCOMPLIANCE 6 0.0001
923 ACCIDENTAL OVERDOSE 4 0.0001
924 SKIN IRRITATION 5 0.0001
925 AMNESIA 7 0.0001
926 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
927 TARDIVE DYSKINESIA 3 0.0001
928 INFUSION RELATED REACTION 7 0.0001
929 VISUAL IMPAIRMENT 13 0.0001
930 MULTIPLE SCLEROSIS 5 0.0001
931 PRODUCT SUBSTITUTION ISSUE 6 0.0001
932 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
933 MYOCARDIAL INFARCTION 18 0.0001
934 CHOKING 2 0.0001
935 INJURY 7 0.0001
936 HEPATIC FAILURE 3 0.0001
937 DEVICE BREAKAGE 4 0.0001
938 VERTIGO 6 0.0001
939 LUNG NEOPLASM MALIGNANT 4 0.0001
940 EMOTIONAL DISORDER 3 0.0001
941 RHEUMATOID ARTHRITIS 11 0.0001
942 FEMUR FRACTURE 3 0.0001
943 NERVOUSNESS 5 0.0001
944 IMPAIRED WORK ABILITY 2 0.0001
945 DRUG EFFECT DECREASED 5 0.0001
946 ACNE 7 0.0001
947 VAGINAL HAEMORRHAGE 4 0.0001
948 EXPIRED PRODUCT ADMINISTERED 3 0.0001
949 ERYTHEMA 18 0.0001
950 GASTRIC DISORDER 3 0.0001
951 ADVERSE EVENT 8 0.0001
952 NIGHTMARE 3 0.0001
953 DEVICE USE ERROR 3 0.0001
954 ARRHYTHMIA 4 0.0001
955 DIABETIC KETOACIDOSIS 2 0.0001
956 C-REACTIVE PROTEIN INCREASED 3 0.0001
957 ILL-DEFINED DISORDER 5 0.0001
958 HEPATIC FUNCTION ABNORMAL 3 0.0001
959 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
960 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
961 CARDIOVASCULAR DISORDER 2 0.0001
962 URTICARIA 13 0.0001
963 DIPLOPIA 2 0.0001
964 DEAFNESS 2 0.0001
965 INCORRECT DOSE ADMINISTERED 17 0.0001
966 INTENTIONAL DOSE OMISSION 2 0.0001
967 ANGIOEDEMA 3 0.0001
968 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
969 THERAPEUTIC RESPONSE DECREASED 4 0.0001
970 DRUG ADMINISTRATION ERROR 2 0.0001
971 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
972 DRUG INEFFECTIVE 71 0.0001
973 CONVULSION 3 0.0001
974 INJECTION SITE HAEMORRHAGE 4 0.0001
975 OVERDOSE 10 0.0000
976 INJECTION SITE PRURITUS 3 0.0000
977 PRODUCT QUALITY ISSUE 6 0.0000
978 BREAST CANCER 4 0.0000
979 DEVICE MALFUNCTION 3 0.0000
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
981 DISEASE RECURRENCE 2 0.0000
982 INJECTION SITE PAIN 12 0.0000
983 PROSTATE CANCER 3 0.0000
984 DRUG ABUSE 3 0.0000
985 INTENTIONAL OVERDOSE 2 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
987 INJECTION SITE REACTION 2 0.0000
988 INJECTION SITE BRUISING 2 0.0000
989 PSORIASIS 3 0.0000
990 INTENTIONAL PRODUCT MISUSE 2 0.0000
991 DRUG DEPENDENCE 3 0.0000
992 NO ADVERSE EVENT 3 0.0000
993 INJECTION SITE ERYTHEMA 2 0.0000